Ticker Report StockNews.com started coverage on shares of Cytosorbents (NASDAQ:CTSO - Get Free Report) in a report issued on Saturday. The brokerage set a "hold" rating on the medical research company's stock. A...\n more…
Ticker Report StockNews.com assumed coverage on shares of Cytosorbents (NASDAQ:CTSO - Free Report) in a report issued on Friday. The brokerage issued a hold rating on the medical research company's stock. A number...\n more…
Ticker Report Shares of Cytosorbents Co. (NASDAQ:CTSO - Get Free Report) crossed above its two hundred day moving average during trading on Thursday . The stock has a two hundred day moving average of $0.94 and...\n more…
Globe Newswire PRINCETON, N.J., Aug. 27, 2024 (GLOBE NEWSWIRE) -- CytoSorbents Corporation (NASDAQ: CTSO), a leader in the treatment of life-threatening conditions in...\n more…
Ticker Report Equities researchers at StockNews.com assumed coverage on shares of Cytosorbents (NASDAQ:CTSO - Get Free Report) in a note issued to investors on Thursday. The brokerage set a "hold" rating on the...\n more…